Conference Agenda

Overview and details of the sessions of this conference. Please select a date or location to show only sessions at that day or location. Please select a single session for detailed view (with abstracts and downloads if available).

Please note that all times are shown in the time zone of the conference. The current conference time is: 4th Dec 2024, 08:01:49pm CET

 
 
Session Overview
Session
PO: Poster Session
Time:
Thursday, 30/May/2024:
10:00am - 4:30pm


Show help for 'Increase or decrease the abstract text size'
Presentations

Exploring Astrocyte-Derived KYNA in Schizophrenia: Insights from a 3D Spheroid Model and Drug Screening Platform

Funda Orhan, Tian Sang, Xueqi Li, Marta Gomez, Sophie Erhardt

Department of Physiology and Pharmacology, Karolinska Institutet, Sweden



A New Pharmacological Treatment Concept for Alcohol Use Disorder: Combined Treatment With a Glycine Transporter-1-Inhibitor, Varenicline and Bupropion

Yasmin Olsson1,2,3,3, Helga Lidö1,2, Karin Ademar1, Davide Cadeddu1, Mia Ericson1, Bo Söderpalm1,2

1Addiction Biology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Sweden; 2Beroendekliniken, Sahlgrenska University Hospital, Gothenburg, Sweden; 3Department of Neurology, Sahlgrenska University Hospital, Sweden



Dysregulation of the kynurenine pathway is related to persistent cognitive impairments in TBE patients

Xueqi Li1, Jacob Ahlberg Weidenfors1, Vytautas Griška2, Fredrik Piehl3,4, Lars Lindquist5, Aukse Mickiene2, Lilly Schwieler1, Sophie Erhardt1

1Department of Physiology and Pharmacology, Karolinska Institutet, 171 77 Stockholm, Sweden; 2Department of Infectious Disease, Lithuanian University of Health Sciences, 44 307 Kaunas, Lithuania; 3Unit of Neuroimmunology, Department of Clinical Neuroscience, Center for Molecular Medicine, Karolinska Institutet, Karolinska University Hospital, 171 77 Stockholm, Sweden; 4Division of Neurology, Karolinska University Hospital, 171 76 Stockholm, Sweden; 5Department of Infectious Disease, Karolinska Institutet, 171 77 Stockholm, Sweden



Innovative CSF collection technique for rats: Understanding kynurenine pathway metabolite translation across brain, plasma and CSF

Varvara Louvrou, Marta Gómez Galán, Sophie Erhardt

Karolinska Institutet, Sweden



Neurophysiological signatures in the Basolateral Amygdala associated with an AUD-like phenotype in rat

Davide Cadeddu, Ana Domi, Erika Lucente, Louise Adermark

University of Gothenburg, Sweden



Integrative analysis multi-omics analysis of proteomics and metabolomics data of Karolinska Schizophrenia Project (KaSP)

Feride Ayten Eren1, Humza Haroon2, Sophie Erhardt1, Doo-Sup Choi3

1Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden; 2Department of Molecular Pharmacology and Experimental Therapeutics, Mayo Clinic College of Medicine and Science, Rochester, MN, USA; 3Department of Psychiatry and Psychology, Mayo Clinic College of Medicine and Science, Rochester, MN, USA



Nicotine produces sex-specific neuroadaptations in the amygdala which in female rats can be reversed by physical activity

Erika Lucente, Ana Domi, Davide Cadeddu, Mia Ericson, Louise Adermark

University of Gothenburg, Sweden



Pharmacological treatment of the core symptoms of Anorexia nervosa – a systematic literature review

Elin Ingrid Munke, Jonas Eberhard, Erik Jedenius, Charalampos Vestakis

Region Skåne, Sweden



Polygenic Risk Score Analysis of Postpartum Psychosis and Cycloid Psychosis

Elin Hörbeck1, Lina Jonsson1, Carl Sellgren2, Mikael Landén1

1Göteborgs Universitet, Sweden; 2Karolinska Institutet, Sweden



THE ACETYLCHOLINE ESTERASE INHIBITOR DONEPEZIL INCREASES ACCUMBAL DOPAMINE LEVELS AND BLOCKS THE ALCOHOL DEPRIVATION EFFECT IN RATS

Anna Loftén1,3, Klara Danielsson1, Louise Adermark2, Mia Ericson1, Bo Söderpalm1,3

1Department of Psychiatry and Neurochemistry, the Sahlgrenska Academy at University of Gothenburg, Sweden; 2Department of Pharmacology, the Sahlgrenska Academy at University of Gothenburg, Sweden; 3Beroendekliniken, Sahlgrenska University Hospital, Sweden



The Pharmacological Effect of Acamprosate Originates from Different Drug Components

Karin Ademar1, Anna Loftén1,3, Mathilda Nilsson1, Ana Domi1,2, Louise Adermark1,2, Bo Söderpalm1,3, Mia Ericson1

1Addiction Biology Unit, Department of Psychiatry and Neurochemistry, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden; 2Department of Pharmacology, Institute of Neuroscience and Physiology, The Sahlgrenska Academy, University of Gothenburg, Sweden; 3Beroendekliniken, Sahlgrenska University Hospital, Gothenburg, Sweden



 
Contact and Legal Notice · Contact Address:
Privacy Statement · Conference: SCNP 2024
Conference Software: ConfTool Pro 2.8.103
© 2001–2024 by Dr. H. Weinreich, Hamburg, Germany